In summary, we present a novel “double hit” high-grade B-cell lymphoma cell line, designated DH-My6, with concurrent MYC/IGH and BCL6/IGH rearrangements. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.